Biogened S.A.

WSE:BGD Rapporto sulle azioni

Cap. di mercato: zł54.0m

Biogened Salute del bilancio

Salute finanziaria criteri di controllo 4/6

Biogened ha un patrimonio netto totale di PLN39.3M e un debito totale di PLN23.3M, che porta il suo rapporto debito/patrimonio netto a 59.2%. Le sue attività totali e le sue passività totali sono rispettivamente PLN87.0M e PLN47.7M. L'EBIT di Biogened è PLN8.4M rendendo il suo rapporto di copertura degli interessi 3.7. Ha liquidità e investimenti a breve termine pari a PLN6.2M.

Informazioni chiave

59.2%

Rapporto debito/patrimonio netto

zł23.29m

Debito

Indice di copertura degli interessi3.7x
Contantizł6.16m
Patrimonio nettozł39.32m
Totale passivitàzł47.66m
Totale attivitàzł86.97m

Aggiornamenti recenti sulla salute finanziaria

Recent updates

Biogened (WSE:BGD) Takes On Some Risk With Its Use Of Debt

Nov 06
Biogened (WSE:BGD) Takes On Some Risk With Its Use Of Debt

A Piece Of The Puzzle Missing From Biogened S.A.'s (WSE:BGD) 25% Share Price Climb

Aug 28
A Piece Of The Puzzle Missing From Biogened S.A.'s (WSE:BGD) 25% Share Price Climb

Impressive Earnings May Not Tell The Whole Story For Biogened (WSE:BGD)

Aug 22
Impressive Earnings May Not Tell The Whole Story For Biogened (WSE:BGD)

Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding

May 23
Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding

Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden

May 09
Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden

Biogened's (WSE:BGD) Promising Earnings May Rest On Soft Foundations

Feb 21
Biogened's (WSE:BGD) Promising Earnings May Rest On Soft Foundations

Is Biogened (WSE:BGD) A Risky Investment?

Feb 01
Is Biogened (WSE:BGD) A Risky Investment?

Biogened S.A. (WSE:BGD) Looks Just Right With A 37% Price Jump

Feb 01
Biogened S.A. (WSE:BGD) Looks Just Right With A 37% Price Jump

We Think Biogened (WSE:BGD) Can Stay On Top Of Its Debt

Jun 30
We Think Biogened (WSE:BGD) Can Stay On Top Of Its Debt

Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Oct 08
Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Is Biogened (WSE:BGD) A Risky Investment?

Jun 29
Is Biogened (WSE:BGD) A Risky Investment?

Does Biogened (WSE:BGD) Have A Healthy Balance Sheet?

Mar 25
Does Biogened (WSE:BGD) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Biogened (WSE:BGD) Is Using Debt Reasonably Well

Dec 09
These 4 Measures Indicate That Biogened (WSE:BGD) Is Using Debt Reasonably Well

Biogened (WSE:BGD) Has A Somewhat Strained Balance Sheet

Jul 29
Biogened (WSE:BGD) Has A Somewhat Strained Balance Sheet

Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Apr 30
Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Is Biogened (WSE:BGD) A Risky Investment?

Jan 24
Is Biogened (WSE:BGD) A Risky Investment?

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( PLN52.7M ) di BGD superano le sue passività a breve termine ( PLN23.4M ).

Passività a lungo termine: Le attività a breve termine di BGD ( PLN52.7M ) superano le sue passività a lungo termine ( PLN24.2M ).


Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: Il rapporto debito netto/patrimonio netto ( 43.6% ) di BGD è considerato alto.

Riduzione del debito: Il rapporto debito/patrimonio netto di BGD è aumentato da 40.6% a 59.2% negli ultimi 5 anni.

Copertura del debito: Il debito di BGD è ben coperto dal flusso di cassa operativo ( 20.1% ).

Copertura degli interessi: I pagamenti degli interessi sul debito di BGD sono ben coperti dall'EBIT ( 3.7 x copertura).


Bilancio


Scoprire le aziende sane